Losartan Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application
This report describes the global market size of Losartan from 2020 to 2024 and its CAGR from 2020 to 2024, and also forecasts its market size to the end of 2030 and its CAGR from 2025 to 2030.
For geography segment, regional supply, demand, major players, price is presented from 2020 to 2030. This report cover following regions: North America South America Asia & Pacific Europe MEA
The key countries for each regions are also included such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.
For competitor segment, the report include global key players of Losartan as well as some small players. The information for each competitor include: Company Profile Business Information SWOT Analysis Revenue, Gross Margin and Market Share
Applications Segment: Hypertension Diabetic nephropathy Reduce the risk of stroke
Companies Covered: Merck Pfizer Teva Pharmaceuticals Sanofi Novartis International Dr. Reddy’s Laboratories Sun Pharmaceuticals Aurobindo Pharma Torrent Pharmaceuticals Lupin Mylan Ipca Laboratories Macleods Pharmaceuticals etc.
Please ask for sample pages for full companies list
Base Year: 2025 Historical Data: from 2020 to 2024 Forecast Data: from 2025 to 2030
Chapter 1 Executive Summary
Chapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter Four Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 Covid-19 Impact
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Losartan Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Losartan Market in North America (2020-2030)
8.1 Losartan Market Size
8.2 Losartan Market by End Use
8.3 Competition by Players/Suppliers
8.4 Losartan Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Losartan Market in South America (2020-2030)
9.1 Losartan Market Size
9.2 Losartan Market by End Use
9.3 Competition by Players/Suppliers
9.4 Losartan Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Losartan Market in Asia & Pacific (2020-2030)
10.1 Losartan Market Size
10.2 Losartan Market by End Use
10.3 Competition by Players/Suppliers
10.4 Losartan Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southest Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Losartan Market in Europe (2020-2030)
11.1 Losartan Market Size
11.2 Losartan Market by End Use
11.3 Competition by Players/Suppliers
11.4 Losartan Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Losartan Market in MEA (2020-2030)
12.1 Losartan Market Size
12.2 Losartan Market by End Use
12.3 Competition by Players/Suppliers
12.4 Losartan Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Losartan Market (2020-2025)
13.1 Losartan Market Size
13.2 Losartan Market by End Use
13.3 Competition by Players/Suppliers
13.4 Losartan Market Size by Type
Chapter 14 Global Losartan Market Forecast (2025-2030)
14.1 Losartan Market Size Forecast
14.2 Losartan Application Forecast
14.3 Competition by Players/Suppliers
14.4 Losartan Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Merck
15.1.1 Company Profile
15.1.2 Main Business and Losartan Information
15.1.3 SWOT Analysis of Merck
15.1.4 Merck Losartan Revenue, Gross Margin and Market Share (2020-2025)
15.2 Pfizer
15.2.1 Company Profile
15.2.2 Main Business and Losartan Information
15.2.3 SWOT Analysis of Pfizer
15.2.4 Pfizer Losartan Revenue, Gross Margin and Market Share (2020-2025)